| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9311733 | Urology | 2005 | 6 Pages |
Abstract
These data suggest that mCRPs are differentially expressed in prostate cancer, with CD55 the predominant mCRP upregulated in malignant prostate epithelial cells. Additionally, CD97 expression correlated with the malignant phenotype and may contribute to the tumorigenic and metastatic potential of prostate cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Robert D. Loberg, Kirk J. Wojno, LaShon L. Day, Kenneth J. Pienta,